澳門:1名由土耳其回澳居民被列爲輸入性新冠無症狀感染者
澳門特區新型冠狀病毒感染應變協調中心昨晚公佈,1名由土耳其經阿聯酋、新加坡回澳門的55歲澳門男居民,本週二(8日)新冠病毒核酸檢測結果呈弱陽性,昨日再次複查核酸檢測結果則爲陰性,判定爲輸入性新冠病毒無症狀感染者。
該人士去年4月、5月在澳門及12月在土耳其共接種3劑的mRNA疫苗。
應變協調中心表示,該人士目前無新冠肺炎症狀,結合其流行病學史、臨牀表現及檢測結果,判定爲輸入性新冠病毒無症狀感染者,不列入澳門新冠病毒肺炎確診病例。(wl/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.